Related Experiment Videos
Structural implications for the design of molecular vaccines
V Apostolopoulos1, M Yu, I F McKenzie
1Department of Molecular Biology and Skaggs Institute for Chemical Biology (BCC-206), Scripps Research Institute, 10550 N Torrey Pines Road, La Jolla, CA 92037, USA. vapos@scripps.edu
Current Opinion in Molecular Therapeutics
|March 16, 2001
Summary
Understanding the 3D structure of major histocompatibility complex (MHC) molecules and their interactions is crucial for designing molecular vaccines. This review covers MHC structures, including those with peptides and T-cell receptors.
Area of Science:
- Immunology and Structural Biology
- Molecular Medicine
Background:
- Major histocompatibility complex (MHC) molecules present antigenic peptides to T-cell receptors (TCRs).
- Recognition of peptide-MHC complexes by cytotoxic T-cells triggers cellular destruction.
Purpose of the Study:
- To review the 3D crystal structures of MHC class I molecules.
- To explore the interactions between MHC, peptides, and TCRs.
- To discuss structures of glycopeptides and alternative T-cell antigens presented by MHC.
Main Methods:
- Review of existing crystallographic data for MHC class I molecules.
- Analysis of structural data concerning peptide binding and TCR engagement.
- Inclusion of structural information on modified peptides (glycopeptides) and non-peptide antigens.
Main Results:
- Detailed insights into the structural basis of peptide presentation by MHC class I.
- Elucidation of the molecular interfaces involved in peptide-MHC/TCR recognition.
- Characterization of structural variations in antigen presentation.
Conclusions:
- Understanding MHC structure is a prerequisite for designing effective molecular vaccines.
- Structural information aids in the development of targeted immunotherapies.
- Further structural studies will enhance vaccine design and understanding of immune responses.